These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 29429442)

  • 1. Heroin detoxification during pregnancy: A systematic review and retrospective study of the management of heroin addiction in pregnancy.
    Gilfillan KV; Dannatt L; Stein DJ; Vythilingum B
    S Afr Med J; 2018 Feb; 108(2):111-117. PubMed ID: 29429442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations on methadone withdrawal in 16 neonates.
    Rahbar F
    Clin Pediatr (Phila); 1975 Apr; 14(4):369-71. PubMed ID: 1120379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance use in pregnancy.
    Wong S; Ordean A; Kahan M; ; ; ; ;
    J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of adverse obstetric outcomes and maternity hospitalization among heroin-exposed and methadone-treated women in Taiwan.
    Chen CY; Lien YT; Yeh HH; Su LW; Ho IK
    Int J Drug Policy; 2015 Feb; 26(2):191-8. PubMed ID: 25171908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone maintenance program in a Swiss perinatal center: (I): Management and outcome of 89 pregnancies.
    Kashiwagi M; Arlettaz R; Lauper U; Zimmermann R; Hebisch G
    Acta Obstet Gynecol Scand; 2005 Feb; 84(2):140-4. PubMed ID: 15683373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone maintenance treatment (MMT): a review of historical and clinical issues.
    Joseph H; Stancliff S; Langrod J
    Mt Sinai J Med; 2000; 67(5-6):347-64. PubMed ID: 11064485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of maternal heroin and methadone use on birthweight.
    Kandall SR; Albin S; Lowinson J; Berle B; Eidelman AI; Gartner LM
    Pediatrics; 1976 Nov; 58(5):681-5. PubMed ID: 980601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of neonatal outcomes amongst a methadone- and/or heroin-dependent population referred to a multidisciplinary Perinatal and Family Drug Health Service.
    Buckley V; Razaghi A; Haber P
    Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):464-70. PubMed ID: 23550533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy in heroin addiction].
    Hosztafi S; Fürst Z
    Neuropsychopharmacol Hung; 2014 Sep; 16(3):127-40. PubMed ID: 25347242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes to methadone clearance during pregnancy.
    Wolff K; Boys A; Rostami-Hodjegan A; Hay A; Raistrick D
    Eur J Clin Pharmacol; 2005 Nov; 61(10):763-8. PubMed ID: 16261362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinatal effects of combined use of heroin, methadone, and amphetamine during pregnancy and quantitative measurement of metabolites in hair.
    Su PH; Chang YZ; Yang C; Ng YY; Chen JY; Chen SC
    Pediatr Neonatol; 2012 Apr; 53(2):112-7. PubMed ID: 22503258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between maternal use of heroin and methadone and infant birth weight.
    Hulse GK; Milne E; English DR; Holman CD
    Addiction; 1997 Nov; 92(11):1571-9. PubMed ID: 9519499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cue-induced craving in Chinese heroin abusers.
    Shi J; Zhao LY; Epstein DH; Zhang XL; Lu L
    Pharmacol Biochem Behav; 2007 May; 87(1):141-5. PubMed ID: 17532034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of buprenorphine in the management of heroin addiction.
    Sung S; Conry JM
    Ann Pharmacother; 2006 Mar; 40(3):501-5. PubMed ID: 16434562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine replacement therapy: a confirmed benefit.
    Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender Differences in Heroin Addiction and Treatment: Results from the VEdeTTE Cohort.
    Vigna-Taglianti FD; Burroni P; Mathis F; Versino E; Beccaria F; Rotelli M; Garneri M; Picciolini A; Bargagli AM;
    Subst Use Misuse; 2016; 51(3):295-309. PubMed ID: 26872763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of propoxyphene napsylate in the treatment of heroin and methadone addiction.
    Inaba DS; Gay GR; Whitehead CA; Newmeyer JA; Bergin D
    West J Med; 1974 Aug; 121(2):106-11. PubMed ID: 4847425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heroin abuse and methadone substitution in pregnancy].
    Vering A; Seeger J; Becker S; Halberstadt E; Bender HG
    Geburtshilfe Frauenheilkd; 1992 Mar; 52(3):144-7. PubMed ID: 1597272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.